COVID-19 Resources and Studies

COVID-19

Guidance for Resuming Health-Related Human Subjects Research

Guidance on resuming health-related human subjects research and clinical trials has been provided by the Office of the Associate VP for Research, CTSI, and OCR.

Office of Clinical Research

UF|Research Resumption Plan – Stage 2

The University of Florida has now begun Stage 2 in the process for reengaging on-campus research activities which have been interrupted by the…

Clinical Research

UF Clinical Research Resumption Plan

The UF Office of Clinical Research has published guidance for resuming clinical research projects, which applies to all UF health-related human…

study team

UF IRB COVID-19 Investigator Guidelines

Investigators may need to alter protocols to minimize the spread of COVID-19. The following outlines if/when IRB needs to be notified.

IRB

Alachua County

Centers for Disease Control and Prevention

Clinical Research Forum

Emerging Pathogens Institute

FDA

Florida Department of Health

National Institutes of Health

OnCore

WHO

UF Health

UF Human Resources

UF IRB

UF Health IT

UF | Research

University of Florida

World Health Organization

Your COVID-19 Good News

Join a COVID-19 Research Study

TitleSummaryRead Details on ClinicalTrials.govStudy ContactsSponsor
A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized AdultsThis study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. NCT04280705
Central Contact
(301) 761-7948
DMIDClinicalTrials@niaid.nih.gov

National Institute of Allergy and Infectious Diseases (NIAID)
An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID-19The primary objective of the study is to evaluate the clinical efficacy of sarilumab relative to the control arm in adult patients hospitalized with COVID-19.NCT04315298Clinical Trials Administrator
(844) 734-6643
clinicaltrials@regeneron.com
Regeneron Pharmaceuticals
Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19The HERO Registry provides a resource for collecting information on Healthcare Workers (HCWs) currently working in the United States. NCT04342806Laura Webb
(919) 668-8977
heroesresearch@duke.edu

Nina Y Hines
(919) 668-3677
heroesresearch@duke.edu
Duke University
Mental Health Impact of COVID-19 Pandemic StudyThe purpose of this study is to learn about how stressors related to the COVID-19 virus affect mental health over time. We hope to better understand the experiences of participants during this difficult time. Participation involves completing online questionnaires every two weeks, for 6 months. The questionnaires take about 20 minutes to complete. You must be at least 18 years old to participate.NCT04339790To find out if you qualify, email NIMHResearchVolunteer@nih.gov or call 1-240-665-0697 [TTY: 1-866-411-1010].National Institute of Mental Health (NIMH)
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)ORCHID is a multicenter, blinded, placebo-controlled, randomized clinical trial evaluating hydroxychloroquine for the treatment of adults hospitalized with COVID-19. NCT04332991

Katie Oldmixon, RN
(617) 726-4777
coldmixon@mgh.harvard.edu

Nancy Ringwood, BSN
(617) 724-9836
nringwood@mgh.harvard.edu
Massachusetts General Hospital & National Heart, Lung, and Blood Institute (NHLBI)
SARS-COV2 Pandemic Serosurvey and Blood SamplingIn this study, researchers want to find people who have anti-SARS-COV2 antibodies but no known exposure or illness.NCT04334954    clinicalstudiesunit@nih.govNational Institute of Allergy and Infectious Diseases (NIAID)
Smell Loss and COVID-19Only individuals who have been tested for COVID-19 at a UF Health clinic may participate in this study.N/Ahttps://ufhealth.org/research-study/smell-loss-and-covid-19-study
 
University of Florida
University of Florida COVID-19 Testing Program in The VillagesThe University of Florida is offering drive-thru coronavirus tests for residents at The Villages who are experiencing symptoms and meet certain other requirements.N/AUFHealthCovid.com
University of Florida